Table of Contents Table of Contents
Previous Page  182 / 400 Next Page
Information
Show Menu
Previous Page 182 / 400 Next Page
Page Background

MONDAY

TUESDAY

WEDNESDAY

THURSDAY

SCIENTIFIC PROGRAMME

174

005

Effects of switching from olanzapine to

aripiprazole on the metabolic profiles of patients

with schizophrenia and metabolic syndrome:

a randomized, open-label study

Rayees Wani, India

Mansoor Dar

006

Clozapine-associated neutropenia and agran-

ulocytosis: results form the pharmacovigilance

intensive program in Argentina

Federico Daray, Argentina

María Victoria Balda, Cintia Romina Prokopez, Arnaldo

Armesto

OS-39

Oral Presentation Session

08:15–09:45

|

Room R4

TOPIC 4:

Affective disorders

Affective disorders: treatment and interventions I

Chairs:

Gregor Hasler, Switzerland

Erich Seifritz, Switzerland

001

Hospital and day hospital treatments for

patients with major depression: psychotherapeutic

program and main results of the INDDEP-study

Jörn von Wietersheim, Germany

Armin Hartmann, Heinz Weiss, Carl-Eduard Scheidt,

Alexander Völker, Annegret Eckhardt-Henn, Manfred

Beutel, Jamie Knoblauch, Peter Rochlitz, Almut Zeeck

002

Who responds to therapeutic sleep deprivation?

A large naturalistic clinical study

Nina Trautmann, Germany

Jerome Foo, Josef Frank, Steffen Conrad von

Heydendorff, Maria Gilles, Stephanie H. Witt, Michael

Deuschle, Marcella Rietschel

003

Metacognitive training for depression: new

results and developments

Lena Jelinek, Germany

Sönke Arlt, Anne Runde, Jürgen Gallinat, Steffen Moritz,

Simone Kühn, Judith Peth

004

Antidepressant treatment effects on dopamine

transporter availability in patients with major

depression: a prospective 123I-FP-CIT SPECT

imaging genetic study

Sabine Hellwig, Germany

Lars Frings, Annette Masuch, Werner Vach, Katharina

Domschke, Claus Normann, Philipp T. Meyer

005

Is psychoeducational family intervention

feasible in the Italian mental health centres?

Findings from an Italian multicentric study

Gaia Sampogna, Italy

Mario Luciano, Benedetta Pocai, Micaela Savorani,

Giuseppina Borriello, Valeria Del Vecchio, Vincenzo

Giallonardo, Andrea Fiorillo

006

Sahaj Samadhi Meditation, belonging to the

category of Automatic Self Transcending Meditation

(ASTM), improves symptoms of late-life depression

Akshya Vasudev, Canada

Emily Ionson, Amer Burhan, Ronnie Newman

OS-40

Oral Presentation Session

08:15–09:45

|

Room R5

TOPIC 13:

Brain imaging, neurophysiology,

neuropsychology

Brain imaging, neurophysiology, neuropsychology III

Chairs:

Armida Mucci, Italy

Oliver Gruber, Germany

001

Hippocampal mean diffusivity for the diagnosis

of dementia and mild cognitive impairment in a

primary care sample

Katharina Brüggen, Germany

Martin Dyrba, Ingo Kilimann, Wolfgang Hoffmann,

Jochen R. Thyrian, Stefan Teipel

002

Modulation of short- and long-term memory

with stimulants: a fMRI study on the cognitive

effects of methylphenidate, caffeine and modafinil

on healthy male individuals

Dimitris Repantis, Germany

Lucas Adam, Martin Dresler, Simone Kuehn

003

Emotion recognition and emotion regulation in

a person with a unilateral amygdala lesion

Katrin Schulze, Germany

Sven Barnow

004

Neurobiology of trait impulsivity: a comparative

VBM study contrasting traditional and alternative

concepts

Bianca Besteher, Germany

Christian Gaser, Igor Nenadic

005

Seed-based resting-state functional connec-

tivity in patients with persistent somatoform pain

disorder (PSPD)

Yanli Luo, People's Republic of China

Xiandi Pan, Chao Yan, Tianming Huang

006

Normative data for Cambridge Neuropsy-

chological Test Automated Battery (CANTAB) for

Sri Lankans: changes of cognitive functions from

adolescence to late adulthood

Dewasmika Ariyasinghe, Sri Lanka

R. G. L. Shiroma, Subhagya Kulatunga, Tharaka

Dassanayake